… Thyroid cancer (TC) is one of the most common malignant tumors, with high morbidity and
… However, due to the high proportion of PTC among all thyroid cancers (about 80%) 11 , …

… In this Seminar, we describe the clinical presentation, diagnostic work-up, and standard
treatment of thyroid nodules and thyroid cancer, and discuss cutting-edge treatments that could …

objective This study was designed to investigate whether an elevated serum antithyroglobulin
antibody (TgAb) reflects cancer recurrence in thyroglobulin (Tg)‐undetectable patients …

… to summarise available evidence for thyroid autoimmunity in differentiated thyroid cancer
and to put it into perspective in relation to its significance in modifying the outcome of DTC. …

… Conclusion: Most TB nodules do not show clinically significant growth over several years of
… to that recommended by the American Thyroid Association thyroid cancer guidelines for the …

… It is likely that with increased interest in the presence of locoregional disease more
micrometastatic disease will be found and its clinical significance called into question. …

… Based on the GLOBOCAN 2020 database of cancer incidence and mortality by the WHO
International Agency for Research on Cancer, thyroid cancer has the ninth highest cancer …

… cancer. In this review, the role of miRNAs in thyroid cancer development is described. The
most common miRNAs detected in thyroid cancer along with their clinical significance are also …

… Median follow-up was 7.6 years for the incidental cases, and in this time span, five cases
of recurrence and no deaths from thyroid cancer occurred. The five-year recurrence-free …

… the origin and progression of papillary thyroid cancer (PTC), which accounts for almost 80%
of all TC cases, and to the diagnostic and clinical implications related to this phenomenon. …